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Background: Mucoepidermoid carcinoma (MEC) can be classified into low-, intermediate-, and high-grade tumors
based on its histological features. MEC is mainly composed of three cell types (squamous or epidermoid, mucous
and intermediate cells), which correlates with the histological grade and reflects its clinical behavior. Most cancers
exhibit reduced methylation of repetitive sequences such as Long INterspersed Element-1 (LINE-1) and Alu
elements. However, to date very little information is available on the LINE-1 and Alu methylation status in MEC. The
aim of this study was to investigate LINE-1 and Alu element methylation in MEC and compare if key differences in
the methylation status exist between the three different cell types, and adjacent normal salivary gland cells, to see if
this may reflect the histological grade.
Methods: LINE-1 and Alu element methylation of 24 MEC, and 14 normal salivary gland tissues were compared
using Combine Bisulfite Restriction Analysis (COBRA). Furthermore, the three different cell types from MEC samples
were isolated for enrichment by laser capture microdissection (LCM), essentially to see if COBRA was likely to
increase the predictive value of LINE-1 and Alu element methylation.
Results: LINE-1 and Alu element methylation levels were significantly different (p<0.001) between the cell types,
and showed a stepwise decrease from the adjacent normal salivary gland to the intermediate, mucous and
squamous cells. The reduced methylation levels of LINE-1 were correlated with a poorer histological grade. In
addition, MEC tissue showed a significantly lower level of LINE-1 and Alu element methylation overall compared to
normal salivary gland tissue (p<0.001).
Conclusions: Our findings suggest that LINE-1 methylation differed among histological grade mucoepidermoid
carcinoma. Hence, this epigenetic event may hold value for MEC diagnosis and prognostic prediction.
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Laser capture microdissectionBackground
Mucoepidermoid carcinoma (MEC) is a malignant neo-
plasm of salivary glands that occurs in both adults and
children [1-4]. MEC typically occurs in 40–60-year-old
patients, and with a median age of approximately 45
years. There is a 3:2 male:female gender preference for
MECs with the exception of the tongue and retromolar
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distribution, and reproduction in any mediumthree percent of MECs are found in the major salivary
glands, especially the parotid glands, while the palate
and the buccal mucosa are the most common intraoral
sites [1].
Histologically, MECs are primarily composed of three
morphological cell types, which include squamous or
epidermoid, mucous and intermediate cells, and these
can take the form of a solid nest or cystic structure.
According to the WHO classification system, MECs are
classified as low-, intermediate- or high-grade based on
five histological features: the presence of a cystic compo-
nent, neural invasion, necrosis, mitotic activity and ana-
plasia [1]. However, many systems have been proposedd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Demographic data of MEC patients
Sample Sex Age Grade Site Cell type
N I M S
MEC1 M 60 Low Palate √ √
MEC2 F 30 Low Palate √ √
MEC3 M 35 Low Palate √ √
MEC4 M 47 High Palate √ √
MEC5 F 38 Low Palate √
MEC6 M 31 Low Palate √ √ √
MEC7 F 32 Low Palate √
MEC8 F 53 High Anterior mandible √
MEC9 M 41 Low Palate √ √
MEC10 F 43 Low Palate √ √
MEC11 M 33 Low Palate √
MEC12 F 55 Intermediate Palate √ √
MEC13 M 54 Low Palate √ √
MEC14 F 34 Intermediate Palate √
MEC15 M 35 Low Palate √
MEC16 F 16 Intermediate Palate √ √ √
MEC17 F 21 Intermediate Palate √ √
MEC18 F 45 Intermediate Palate √ √
MEC19 F 51 High Parotid gland √ √
MEC20 M 31 Intermediate Parotid gland √ √
MEC21 F 53 Intermediate Parotid gland √ √ √
MEC22 F 17 Low Palate √
MEC23 F 41 Intermediate Palate √ √ √ √
MEC24 M 55 Intermediate Palate √
MEC: Mucoepidermoid carcinoma, M: Male, F: Female, Low: Low-grade MEC,
Intermediate: Intermediate-grade MEC,
High: High-grade MEC, N: Adjacent normal salivary gland cell, I: Intermediate
cell, M: Mucous cell, S: Squamous cell.
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sally accepted [1,6-10]. Sadly, the outcome of MEC pa-
tients is influenced by the clinical stage and histological
grade [11], whereby patients with high-grade, the rate
of recurrence and metastasis is increased and thus
compromising survival [1,12,13]. Furthermore, it has
been suggested that the histological grade of MEC
can considerably impact the treatment outcome of af-
fected patients.
To date, only a few genetic studies have proposed
mechanisms for the etiology of MEC. Some MECs have
been reported to have a t(11:19)(q21:p13) translocation,
and abnormality [14-16] that is also shared by acute leu-
kemias [1,17-19]. Furthermore, a study reported that
18% of MECs analyzed demonstrated mutations in H-ras
gene at codon 12 and/or 13 (and none at codon 61), but
however these were essentially detected in high-grade
cases [1,20].
One of the most common epigenetic changes found in
cancer is the genome-wide decrease in methylation (gen-
ome-wide hypomethylation) [21-23]. Long INterspersed
Element-1s (LINE-1s) are retrotransposons with highly
repetitive, interspersed sequences which are distributed
randomly throughout the genome, and constituting 17%
of the total human genome [24,25]. Furthermore, Alu
represents the most abundant Short INterspersed Elem-
ent (SINE) repetitive sequence, representing 11% of total
human genome [26]. Hypomethylation of LINE-1s,
which occurs in many malignancies [21,27-31], gen-
erally results in chromosomal aberrations [32-35],
hypermethylation, mutations of key tumor suppressor
genes [36,37], and changes in oncogene transcription
[38] resulting in the altered expression of cancer-related
genes [39]. In addition, LINE-1 hypomethylation levels
may hold value as a prognostic marker for epithelial solid
cancers, for example cervical [30], hepatocellular [31]
and ovarian [29]. Similarly, Alu hypomethylation have
also been reported for many types of cancers, such as
colorectal [27], gastric [28], and hepatocellular [40].
Thus, both LINE-1 and Alu element hypomethylation
may play a notable role in different histological fea-
ture of cancer.
Most methylation studies report only quantitative in-
formation about the methylation level. Recently, we
reported that the methylation patterns of LINE-1s could
provide more crucial information regarding carcinogen-
esis. For instance, the percentage of hypomethylation
loci (%uCuC) had a value that could significantly distin-
guish between normal peripheral blood mononuclear
cells (PBMCs) and PBMCs from patients with cancers of
the oral cavity, liver, colon, lung and the nasopharynx
[41,42]. In this regard, no study has been carried out to
analyze LINE-1 and Alu element methylation in human
MEC. Thus, the goal of this study was to investigate levelsand patterns of LINE-1 and Alu element methylation in
MEC and also in the three cell types that are affected by
this malignancy. The relationship of methylation status
and histological grade in MEC was also assessed to obtain
a better understanding of the clinical behavior of the
tumor. Here, we demonstrate the methylation level of
LINE-1 was different among the three histological
grades of mucoepidermoid carcinoma.
Methods
Samples and LCM
The research protocol together with the experimental
design underwent approval by the Institutional Review
Board of the Faculty of Medicine, Chulalongkorn Uni-
versity (IRB006/53). Paraffin-embedded tissues from 24
salivary glands from MEC patients (diagnosed by hist-
ology) and 14 normal salivary glands from unrelated
patients were obtained from the Department of Path-
ology, Faculty of Medicine, Chulalongkorn University.
Figure 1 LINE-1 and Alu methylation patterns. The dark circles represent methylated cytosine, while the hollow circles represent
unmethylated cytosine. There are four possible methylation patterns for the LINE-1 and Alu amplicons, including hypermethylated loci (mCmC),
hypomethylated loci (uCuC), and 2 partially methylated loci (mCuC and uCmC). In each model, TaqI specifically identified methylated cytosine, while
TasI specifically identified unmethylated cytosine. (A) The different methylation patterns of LINE-1 resulted in four differently sized digested
products of 160 bp, 98 bp, 80 bp and 62 bp. (B) The different methylation patterns of the Alu element resulted in four differently sized digested
products of 117 bp, 74/75 bp, 42/43 bp and 32 bp.
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tient was obtained from records, and this is shown in
Table 1. The MEC group consisted of 14 women and
10 men (mean age ± SD = 39.62 ± 12.37 years).
These specimens were cut into 3-μm-thick sections
and mounted onto histological glass slides. After
deparaffinization, and hydration, the sections underwent
standard hematoxylin and eosin (H&E) staining. After,
each slide underwent, histopathological evaluation byFigure 2 Comparison of the frequency of total LINE-1 methylation (m
frequency of mC of LINE-1s among MEC cell subtypes showed a stepwise d
(M) and squamous cells (S). The p-‐value between each group is shown in
among cell types showed a stepwise increase from normal cells to interme
each group is shown in the table above the graph.three independent pathologists (SK, KD and NK), and
those cases correctly identified as MECs were histologi-
cally graded according to the WHO diagnostic criteria
[1]. The MEC samples assessed yielded low (n=12),
intermediate (n=9) and high-grade (n=3) samples based
on the 5 histological features (the presence of a cystic
component, neural invasion, necrosis, mitotic activity
and anaplasia) [1,6,43,44]. For the control group, normal
salivary gland tissues were obtained (n=14) from patientsC) and uCuC of LINE-1s among MEC cell subtypes. (A) The
ecrease from normal cells (N) to intermediate cells (I), mucous cells
the table above the graph. (B) The frequency of uCuC of LINE-1s
diate cells, mucous cells and squamous cells. The p-‐value between
Table 2 Frequency of LINE-1 methylation patterns in MEC cell subtypes, whole MEC tissues and normal salivary glands
LINE-1 patterns %mC %mCmC %mCuC %uCmC %uCuC
Adjacent normal salivary gland cell (N) 41.13±2.51 12.49±4.61 26.21±4.62 31.06±7.35 30.22±5.08
Intermediate cell (I) 37.69±0.69 7.63±3.15 27.17±0.50 32.94±5.92 32.24±3.20
Mucous cell (M) 35.84±2.24 11.98±7.93 22.90±6.43 24.80±9.75 40.30±6.92
Squamous cell (S) 31.27±3.07 8.74±5.20 24.17±4.00 20.89±8.10 46.18±4.75
Normal salivary gland (NG) 41.79±1.90 21.03±2.31 28.13±2.95 13.38±3.26 37.44±2.86
Whole MEC tissue (MEC) 35.69±2.23 11.52±4.71 26.64±3.20 21.69±6.96 40.13±3.71
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salivary glands were confirmed by histological analysis to
be free of tumor cells.
MEC tissues underwent laser capture microdissection
(LCM) using the method described in our previous study
[23]. Using our expertise in LCM, we isolated pure cell
population of different MEC subtype, as well as normal
salivary gland cells adjacent to the lesion. From 24 MEC
samples, cell subtypes isolated included squamous
(n=13), intermediate (n=4), mucous (n=16), and adjacent
normal salivary gland (n=12). Approximately 1,500 cells
were isolated from each specimen and used for DNA ex-
traction to yield sufficient amount and quality for PCR
analysis (Table 1).
DNA extraction
DNA was extracted from laser-captured microdissected
tissue by proteinase K digestion and a standard phenol-
chloroform extraction protocol [45]. For whole MEC
tissue anaysis, the paraffin-embedded tissues were cut into
4-μm-thick sections, and DNA was extracted using a
DNA extraction kit (QIAampW DNA FFPE Tissue, Qiagen,
Valencia, CA, USA), and the method described previously
[46]. The quality of DNA was assessed by NANO Drop
2000C, spectrophotometer with ratio of 1.8-2.0.
Combine Bisulfite Restriction Analysis (COBRA) of LINE-1
and Alu element
All DNA samples were treated with sodium bisulfite
essentially following guidelines provided (EZ DNA
Methylation-Gold™ Kit, Zymo research corp, Orange,
CA, USA). For COBRALINE-1, the bisulfate-treated
DNA was subjected to 40 PCR cycles with LINE-1-F (5’-Table 3 Frequency of Alu element methylation patterns in ME
glands
Alu patterns %mC
Adjacent normal salivary gland cell (N) 65.10±2.80
Intermediate cell (I) 63.18±1.51
Mucous cell (M) 61.48±2.46
Squamous cell (S) 57.51±2.46
Normal salivary gland (NG) 64.52±4.66
Whole MEC tissue (MEC) 57.49±5.35CCGTAAGGGGTTAGGGAGTTTTT-3’) and LINE-1-R
(5’-RTAAAACCCTCCRAACCAAATATAAA-3’) primers
at an annealing temperature of 50°C. For COBRAAlu,
the bisulfite-treated DNA was subjected to 40 cycles of
PCR with two primers, Alu-F (5’-GGCGCGGTGGT
TTACGTTTGTAA-3’) and Alu-R (5’-TTAATAAA
AACGAAAT TTCACCATATTAACCAAAC-3’) at an
annealing temperature of 53°C. After PCR amplification,
the LINE-1 amplicons (160 bp) were digested with TaqI
and TasI in NEB buffer 3 (New England Biolabs,
Ontario, Canada), while the Alu amplicons (117 bp)
were digested with TaqI in TaqI buffer (MBI Fermentas,
Burlington, Canada). Both digestion reactions were incu-
bated at 65°C overnight. The LINE-1 and Alu element
digested products were then electrophoresed on an 8%
non-denaturing polyacrylamide gel and stained with
the SYBR green nucleic acid gel stain (Gelstar, Lonza,
Rockland, ME, USA). Distilled water was used as
negative control. All experiments were performed in
duplicate.
LINE-1 methylation analysis
The intensities of the COBRALINE-1 fragments on the
polyacrylamide gel were quantified and analyzed using a
Phosphoimager and the ImageQuant Software (Molecu-
lar-Dynamics, GE Healthcare, Slough, UK). COBRALINE-
1 generated 4 products depending on the methylation
state of the 2 CpG dinucleotides, as follows: partial methy-
lation (mCuC, 160 bp), hypomethylation (uCuC, 98 bp), 1
methylated CpG (mC, 80 bp) and 1 unmethylated CpG
(uC, 62 bp) (Figure 1A). LINE-1 methylation levels and
patterns were calculated to determine the precise percent-








Figure 3 Comparison of the frequency of total Alu element methylation (mC) and uCuC of Alu elements among MEC cell subtypes. (A)
Alu element methylation among cell types showed a stepwise decrease from normal cells to intermediate cells, mucous cells and squamous cell.
The p-‐value between each group is shown in the table above the graph. (B) The frequency of uCuC of Alu elements among cell types showed a
stepwise increase from normal cells to intermediate cells, mucous cells and squamous cells. The p-‐value between each group is shown in the
table above the graph.
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divided by the length (bp) of the double-stranded DNA: %
160/160 = A, %98/94 = B, %80/78 = C and %62/62 = D.
Next, the frequency of each methylation pattern was cal-
culated: percentage of mC = 100×(C+A)/(C+A+A+B+D),
percentage of mCuC = 100×(A)/(((C-D+B)/2)+A+D), per-
centage of uCmC = 100×(D-B)/(C-D+B)/2)+A+D, percent-
age of hypomethylated loci (uCuC) = 100×B/(((C-D+B)/2)
+A+D) and percentage of hypermethylated loci (mCmC)
= 100×((C-D+B)/2)/(((C-D+B)/2)+D+A). DNA samples
isolated from HeLa, Jurkat and Daudi cell lines were used
as positive controls in each experiment and for interassay
variation normalization [21].Alu element methylation analysis
The ImageQuant Software (Molecular-Dynamics) was
used to quantify the intensities of COBRAAlu fragments
on the polyacrylamide gel. COBRAAlu generated 3
bands based on the methylation status: hypomethylation
(uCuC, 117 bp), partial methylation (mCuC and uCmC, 74
and 75 bp, respectively) and methylated loci (mC, 42 and
43 bp) (Figure 1B). Alu element methylation levels and
patterns were calculated to determine the precise fre-
quency of each pattern. The calculation was performed
as the follows. First, the intensity of each band was di-
vided by the length (bp) of the double-stranded DNA: %
117/117 = A, %74 and 75/74.5 = B, %42 and 43/43.5 =
D, and D-B = C (C= hypermethylated loci, mCmC). Next,
the frequency of each Alu element methylation patternwas calculated as follows: percentage of methylated loci
(mC) = 100×(2C+2B)/(2A+2B+2C) = 100×(2D)/(2A+2D),
percentage of hypermethylated loci (mCmC) = 100× C/
(A+B+C), percentage of partially methylated loci (uCmC
+mCuC) = 100×B/(A+B+C) and percentage of
hypomethylated loci (uCuC) = 100×A/(A+B+C). DNA
samples from HeLa, Jurkat and Daudi cell lines were
used as positive controls in every experiment and to
standardize interassay variation [21].Statistical analysis
Analysis of variance (ANOVA) was used to compare
methylation patterns of LINE-1 and Alu elements
among squamous, mucous, intermediate and adjacent
normal salivary gland cells present in MEC lesions, as
well as a paired t-test to analyze among cell subtypes in
paired samples. An independent sample t-test was
performed to determine differences between LINE-1 and
Alu element methylation patterns in total MEC tissue
and normal tissue of the salivary gland. A receiver oper-
ating characteristic (ROC) analysis was performed to
verify the ability of COBRALINE-1 and COBRAAlu to
differentiate MEC lesions from normal salivary gland tis-
sue. An area under the ROC curve (AUC) value of 1.0
indicated perfect accuracy, while an AUC value of 0.5 in-
dicated an inability to distinguish between samples. The
cut-off values were selected to determine the diagnostic
value of this approach. All calculations were performed
using the SPSS software for Windows, version 17.0
Figure 4 LINE-1 and Alu element methylation levels among MEC cell subtypes. (A) LINE-1 methylation in MEC cell subtypes correlated with
the histological grade of the MEC. (B) Alu element methylation level in MEC cell subtypes did not correlate with the histological grade of the
MEC. (C) LINE-1 methylation level of each microdissected MEC specimen. (D) Alu element methylation level of each microdissected
MEC specimen.
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ware. The results were considered statistically significant
when the p-value was less than 0.05.
Results
LINE-1 methylation in microdissected MEC tissue
The frequency of each LINE-1 methylation pattern is
shown in Table 2. The total LINE-1 methylation level
(mC) decreased from the adjacent normal salivary gland
cells (N) to the intermediate cells (I), mucous cells (M)
and squamous cells (S). The results showed significant
differences between S:M, S:I, S:N and M:N (p<0.001).
However, there was no significant difference between M:
I and N:I (p=1.000 and 0.138, respectively) (Figure 2A).Additionally, the frequency of unmethylated (uCuC)
LINE-1s increased from N to M, I and S. Significant dif-
ferences were found between S:M (p=0.048), S:I, S:N and
M:N (p<0.001). However, no significant difference was
found between M:I and N:I (p=0.087 and 1.000, respect-
ively) (Figure 2B). A significant difference in the uCmC
level of LINE-1s in N, M, I and S was found only be-
tween S:N (p=0.027). There was no significant difference
between S:I (p=0.099), M:I (p=0.551), M:N (p=0.353), S:
M and N:I (p=1.000).
The paired comparisons among cell types displayed
strongly significant difference (p<0.001) of mC between
N:M, N:S and M:S. Furthermore, the uCuC is also differ-
ent when compared between N:M (p=0.013), N:S
Figure 5 Comparison of total LINE-1 and Alu element methylation between normal salivary gland tissue and whole MEC tissue. (A, B)
The frequency of mC and mCmC of LINE-1 methylation in whole MEC tissue was significantly lower than in normal salivary gland tissue (p<0.001).
(C) The frequency of mC of Alu elements in whole MEC tissue was significantly lower than in normal salivary gland tissue (p=0.001). (D) The
frequency of uCuC Alu elements in whole MEC tissue was significantly higher than in normal salivary gland tissue (p=0.001).
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comparisons are shown in Additional file 1: Table S1.Alu element methylation in microdissected MEC tissue
The frequency of each Alu element methylation pattern
is shown in Table 3. Similar to LINE-1, total Alu element
methylation (mC) decreased from N to M, I and S. The
results showed significant differences between S:M
(p=0.001), S:I (p=0.002), S:N (p<0.001) and M:N
(p=0.003). However, there was no significant difference
between M:I and N:I (p=1.000) (Figure 3A).
On the contrary, the frequency of uCuC of Alu ele-
ments increased from N to M, I and S, respectively. A
significant difference was found between S:M (p=0.001),
S:I (p=0.002), S:N (p<0.001) and M:N (p=0.003). No sig-
nificant difference was found between M:I and N:I
(p=1.000) (Figure 3B).
A significant difference in the percentage of mCuC +
uCmC of Alu elements was found between S:M
(p=0.028) and S:N (p=0.011). However, there was no sig-
nificant difference between S:I (p=0.061), M:N, M:I and
N:I (p=1.000). Moreover, the frequency of mCmC of Aluelements showed no significant difference between
groups of microdissected cells.
For the paired comparisons, significant differences in
both mC and uCuC of Alu elements were observed as
followed: N:M (p=0.032), N:S (p<0.001) and I:M
(p=0.008). The detailed data of paired comparisons are
shown in Additional file 1: Table S1.LINE-1 and Alu element methylation in MECs of various
histological grades
Total LINE-1 methylation levels (mC) of microdissected
cells in each cell type decreased from low-grade to
intermediate-grade and high-grade MEC, p<0.001
(Figure 4A). However, total Alu element methylation
(mC) in microdissected cells was not related to the histo-
logical grade of the MEC (Figure 4B). Interestingly, when
we compared the total LINE-1 and Alu element methy-
lation levels of microdissected cells in each specimen,
more than 80% of the cases showed decreasing levels of
LINE-1 and Alu element methylation from N to I, M
and S. (Figure 4C, D). These results demonstrate that
genomic hypomethylation, and specifically LINE-1
Figure 6 ROC curve analysis of LINE-1 and Alu element methylation for MEC detection. (A) The total LINE-1 methylation level (mC). (B) The
mCmC level of LINE-1 methylation. (C) The total Alu element methylation level (mC). (D) The uCuC level of Alu element methylation.
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logical grade of MECs.
LINE-1 and Alu element methylation in whole MEC tissue
We next asked whether these methods could be used to
detect and correctly classify MECs. To address this
question, we analyzed LINE-1 and Alu element methyla-
tion in whole MEC tissues, and compared with normal
salivary gland material.
The frequency of each LINE-1 methylation pattern in
whole MEC tissue is shown in Table 2. The frequency of
mC and mCmC LINE-1s were significantly lower in MEC
tissue than in normal salivary gland tissue (p<0.001)
(Table 2, Figure 5A and B). Moreover, the frequency of
mC of LINE-1s in the low-grade MECs was higher than
in intermediate-grade (p<0.001) and high-grade MECs
(p<0.001), respectively (Figure 5A and B).
The frequency of each Alu element methylation pat-
tern in whole MEC tissue is shown in Table 3. Similar to
LINE-1, the total Alu element methylation level (mC) in
MEC tissue was also significantly lower than in normal
salivary gland tissue (p=0.001). In agreement with theseresults, the frequency of uCuC of Alu elements in MEC
tissue was significantly higher than in normal salivary
gland tissue (p=0.001) (Table 3, Figure 5C and D). How-
ever, Alu element methylation in whole MEC tissue was
not related to the histological grade of the MEC
(Figure 5C and D).
Receiver operating characteristic (ROC) analysis of LINE-1
and Alu element methylation
Next, we assessed the ability of these methods to dis-
criminate between MEC tissue and normal salivary
gland tissue using an ROC analysis. Among the vari-
ous patterns of LINE-1 methylation, both the mC and
the mCmC patterns yielded ROC values indicative of
diagnostic reliability. For the mC pattern of LINE-1,
the area under the ROC curve (AUC) value was
0.974, while the cut-off value, sensitivity and specifi-
city were 38.73%, 100% and 92.86%, respectively
(Figure 6A). The AUC value of the mCmC pattern of
LINE-1 was 0.969, while the cut-off value, sensitivity
and specificity were 38.73%, 92.86% and 100%, re-
spectively (Figure 6B).
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lation, the mC and uCuC patterns demonstrated rea-
sonable diagnostic values. Both the mC and the uCuC
of Alu element methylation patterns had AUC values,
sensitivity and specificity of 0.847, 100% and 64.29%,
respectively. The cut-off values for the mC and uCuC
of Alu element methylation patterns were 15.48% and
34.48%, respectively (Figure 6C and D). These results
indicate that ROC analysis of LINE-1 methylation
may have a stronger diagnostic value than analysis of
Alu element methylation. This analysis is especially
more effective when both the mC and mCmC patterns
of LINE-1 methylation are assessed.Discussion
To the best of our knowledge, this report represents the
first epigenetic study of human MEC. We characterized
the methylation status of the repetitive sequences in
clinical samples of MEC, and our results clearly show
that LINE-1 hypomethylation is in concordant with a
poorer histological grade. The COBRA technique repre-
sents an excellent approach for detecting the methyla-
tion status [41,47], and using for example COBRALINE-
1 and COBRAAlu, both are effective in detecting
genome-wide methylation status of LINE-1s and Alu ele-
ments, respectively, in genomic DNA [48]. In our study,
we used a modified method for COBRALINE-1 and
COBRAAlu assessing the methylation status, as shown
in Figure 1. These methods detected 2 CpG dinucleotide
sites and can explain not only methylation level but
also methylation patterns which was not reveal by
pyrosequencing technique [41].
Although MEC is the most common salivary gland
cancer, the overall incidence of occurrence in human
is extremely low and thus rarely diagnosed. Therefore,
one of the limitations of our study is the small num-
ber of MEC samples available for investigation. The-
oretically, the parotid gland is the most common site
of this tumor; however most of MEC samples used in
this study were collected from the minor salivary
glands of the palate. In this context, to maximize the
number of samples available for analysis, we used
laser capture microdissection (LCM), essentially as we
have previously shown that this is a very sensitive
method for isolating a minimal number cells of inter-
est from whole tissue sections and performing mo-
lecular analysis on the extracted nucleic acid. In this
study, we procured ~1,500 microdissected cells, which
provided sufficient DNA to allow the detection of
LINE-1 and Alu methylation levels and pattern. How-
ever, LCM did not allow the sufficient isolation of all
three cell types from most of the MEC cases, but
with some exceptions, for example cases MEC23(Figure 4C and D), we could efficiently collected
every cell population for analysis.
From our data we found that LINE-1 and Alu methy-
lation levels were different among the three histo-
logical grades of MEC. We also observed that LINE-1
hypomethylation in adjacent normal salivary gland cells
was dependent on the histological grade of the MEC
(Figure 4A). This appearance may be explained by some
signaling proteins released by cancer cells that can have
an influence on normal surrounding tissue in the nearby
vicinity [49]. Moreover, the level of LINE-1 methylation
in intermediate cells was between that of adjacent normal
salivary glands and mucous cells which seem to be corre-
lated with the hypothesis proposed by Luna (2006).
According to this author, the intermediate cells, which
are derived from reserve cells of salivary duct unit, are
believed to be the progenitor cells of the other three cell
types of MEC (mucous cells, epidermoid cells and clear
cells), and thus they may represent cells in halfway of dif-
ferentiation between normal reserve cells and the other
three cell types of MEC [50]. Since we could not measure
the methylation level directly from the reserve cells as
they are extremely hard to be identified by microscopic
examination, we cannot conclude that the LINE-1
methylation level decrease along the pathway of cell dif-
ferentiation from the reserve cells of salivary duct
unit to the other three cell types of MEC as proposed
by Luna (2006).
In conclusion, our findings provide preliminary in-
formation of methylation levels between different cell
components in MEC, which may be related to histo-
logical grading and prognosis of the neoplasm. The
knowledge may be applied as a diagnostic tool or a prog-
nostic marker for these tumors in addition to histo-
logical grading.
Additional file
Additional file 1: Table 1. Paired comparison of LINE-1 and Alu
methylation patterns among MEC cell subtypes.
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